日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metachronous triple primary malignancies: a case report of NGS-guided multidisciplinary management and literature review

异时性三原发恶性肿瘤:NGS指导下多学科诊疗的病例报告及文献综述

Li, Xiangxue; Zhang, Lihua; Wang, Xiaowei; Lv, Jing; Liu, Caiqi; Zhang, Siyi; Li, Xiaoxuan; Song, Jialin; Qiu, Wensheng; Zhao, Shufen

Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review

EGFR突变型小细胞肺癌转化的潜在治疗选择:病例报告及文献综述

Li, Xiaoxuan; Luan, Xinchi; Zhang, Mengqi; Wang, Rui; Guo, Jing; Lv, Jing; Qiu, Wensheng; Zhao, Shufen

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients

HIGD1B作为一种新型预后生物标志物,参与调控肿瘤微环境和免疫细胞浸润;其过表达会导致胃癌患者预后不良。

Wang, Shibo; Zhang, Siyi; Li, Xiaoxuan; Li, Xiangxue; Zhao, Shufen; Guo, Jing; Wang, Shasha; Wang, Rui; Zhang, Mengqi; Qiu, Wensheng

Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker

胃癌中氧化应激和铁死亡相关预后特征的构建及CDH19作为新型生物标志物的鉴定

Wang, Shibo; Zhang, Siyi; Li, Xiaoxuan; Leng, Chuanyu; Li, Xiangxue; Lv, Jing; Zhao, Shufen; Qiu, Wensheng; Guo, Jing

Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort

构建术前化疗后伴同步肝转移的结直肠癌预后模型:基于SEER数据库和外部验证队列的研究

Ding, Yixin; Han, Xiaoxi; Zhao, Shufen; Wang, Shasha; Guo, Jing; Leng, Chuanyu; Li, Xiangxue; Wang, Kongjia; Qiu, Wensheng; Qi, Weiwei

The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma

肝动脉灌注化疗联合抗程序性死亡蛋白1单克隆抗体免疫疗法在晚期肝细胞癌治疗中的重要作用

Ding, Yixin; Wang, Shasha; Qiu, Zhenkang; Zhu, Chunyang; Wang, Yan; Zhao, Shufen; Qiu, Wensheng; Wang, Kongjia; Lv, Jing; Qi, Weiwei

Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022)

全球癌症免疫疗法中B7-H3的研究趋势:文献计量分析(2012-2022)

Huang, Xiaojuan; Guo, Jing; Wang, Shasha; Lin, Zhongkun; Zhao, Shufen; Li, Wenqian; Wang, Yan; Zhu, Chunyang; Lv, Jing; Qiu, Wensheng

Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression.

着丝粒支架 1 (KNL1) 在泛癌肿瘤发生和肿瘤免疫微环境中的作用:生物信息学分析和表达验证

Ding Yixin, Wang Kongjia, Zhao Shufen, Li Yu, Qiu Wensheng, Zhu Chunyang, Wang Yan, Dong Chen, Liu Jiani, Lu Yangyang, Qi Weiwei

Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy

用石蒜碱纠正肿瘤抑制因子 Salvador 同源物-1 的缺乏作为肺癌治疗的新策略

Zhe Zhao, Shufen Xiang, Jindan Qi, Yijun Wei, Mengli Zhang, Jun Yao, Tong Zhang, Mei Meng, Xiaohua Wang, Quansheng Zhou

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer

RAD51异常调控促进ER阳性乳腺癌对新辅助内分泌治疗的耐药性

Yan Jia ,Yueshuai Song ,Guolei Dong ,Chunfang Hao ,Weipeng Zhao ,Shufen Li ,Zhongsheng Tong